Browsing: EG.5

Dr. Silverose Ann Bacolcol, Head of Manila Doctors’ Hospital Infection Prevention and Control Office, shared that “Most of the COVID-19 cases we see now are mild to moderate infections and can be managed at home. However, patients who have risk factors for disease progression, such as the elderly, those with co-morbid conditions, and are immunocompromised, need close monitoring and may have to be admitted.”

Dr Bacolcol strongly advised to receive a booster shot. She stated, “people should still receive their booster shots for COVID-19 because the threat of COVID-19 infection still exists and will continue to stay. The US CDC and Philippine DOH recommend the COVID-19 booster to prevent serious illness, hospitalisation, and death due to COVID-19.” About 23 million Filipinos have received a booster shot.

Singapore grapples with a fresh wave of COVID-19 infections, with Health Minister Ong Ye Kung anticipating higher hospitalisation rates in…

The US Food and Drug Administration (FDA) has greenlit new COVID-19 boosters for both Moderna and Pfizer, marking a proactive step in the fight against rapidly spreading infections in the country. Concurrently, Moderna and Pfizer have announced that their updated COVID-19 vaccines show a robust response against the BA.2.86 subvariant, a mutated version of the coronavirus.

A recent emergence of the EG.5 Omicron subvariant has sparked global attention. We delve into its characteristics and potential implications.